Phase III randomized study of a goserelin acetate for preservation of ovarian function in patients with primary breast cancer (PBC).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Goserelin (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 09 May 2016 Biomarkers information updated
- 30 Sep 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Sep 2009 Planned end date (1 Aug 2012) added as reported by ClinicalTrials.gov.